Primary hepatitis C virus infection in an intravenous drug user: kinetics of virological markers

被引:0
|
作者
Zachary, Pierre [1 ]
Wendling, Marie-Josee [1 ]
Djeddi, Saadi [1 ]
Schvoerer, Evelyne [1 ]
Ullmann, Murielle [1 ]
Stoll-Keller, Francoise [1 ]
Gut, Jean-Pierre [1 ]
机构
[1] Hop Univ Strasbourg, Virol Lab, Serv 3440, F-67000 Strasbourg, France
来源
关键词
D O I
10.1016/S0399-8320(06)73576-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1419 / 1420
页数:2
相关论文
共 50 条
  • [1] Hepatitis C virus infection in intravenous drug users
    Harder, J
    Walter, E
    Riecken, B
    Ihling, C
    Bauer, TM
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (08) : 768 - 770
  • [2] Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers
    Liaw, YF
    Tsai, SL
    Sheen, IS
    Chao, M
    Yeh, CT
    Hsieh, SY
    Chu, CM
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03): : 354 - 359
  • [3] Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection
    Sandmann, Lisa
    Ohlendorf, Valerie
    Ehrenbauer, Alena
    Bremer, Birgit
    Kraft, Anke R. M.
    Cornberg, Markus
    Deterding, Katja
    Wedemeyer, Heiner
    Maasoumy, Benjamin
    LIVER INTERNATIONAL, 2025, 45 (02)
  • [4] Two successive hepatitis C virus infections in an intravenous drug user
    Proust, B
    Dubois, F
    Bacq, Y
    Le Pogam, S
    Rogez, S
    Levillain, R
    Goudeau, A
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (08) : 3125 - 3127
  • [5] Treatment of hepatitis C virus infection in intravenous drug users
    Cowan, Matthew L.
    Maxwell, James D.
    ACTA NEUROPSYCHIATRICA, 2006, 18 (05): : 183 - 192
  • [6] Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy
    Asselah, T
    Vidaud, D
    Doloy, A
    Boyer, N
    Martinot, M
    Vidaud, M
    Valla, D
    Marcellin, P
    GUT, 2003, 52 (06) : 900 - 902
  • [7] HEPATITIS C VIRUS REINFECTION FOLLOWING SUSTAINED VIROLOGICAL RESPONSE IN INTRAVENOUS DRUG USERS
    Manolakopoulos, S.
    Kranidioti, H.
    Karatapanis, S.
    Tsirogianni, E.
    Goulis, J.
    Deutsch, M.
    Anagnostou, O.
    Margaritopoulos, D.
    Papatheodoridis, G.
    Pectasides, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S532 - S532
  • [8] Recommendations for the management of hepatitis C virus infection among intravenous drug users
    Grebely, Jason
    Robaeys, Geert
    Bruggmann, Philip
    Aghemo, Alessio
    Backmund, Markus
    Bruneau, Julie
    Byrne, Jude
    Dalgard, Olav
    Feld, Jordan J.
    Hellard, Margaret
    Hickman, Matthew
    Kautz, Achim
    Litwin, Alain
    Lloyd, Andrew R.
    Mauss, Stefan
    Prins, Maria
    Swan, Tracy
    Schaefer, Martin
    Taylor, Lynn E.
    Dore, Gregory J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2023, 111
  • [9] Factors associated with persistent hepatitis G virus and hepatitis C virus infection in intravenous drug users.
    Toniutto, P
    Gasparini, V
    Fabris, C
    Lombardelli, T
    Falleti, E
    Mattiuzzo, M
    Maurizio, R
    Pirisi, M
    HEPATOLOGY, 1997, 26 (04) : 1952 - 1952